Table 3.
The number of antimicrobial resistant mutants with resistance-associated mutations
| Resistance mechanism | CIPR | MECR | NITR | TMPR | |
|---|---|---|---|---|---|
| Drug target | Modification | 10a | 6 | ||
| Overproduction | 6 | ||||
| Drug activation | Nitroreductase disruption | 10 | |||
| Drug uptake | Porin mutation | 1 | |||
| Efflux | AcrAB-TolC | 7 | 1 | ||
| MdtK | 9 | 1 | |||
| MdfA | 1 | ||||
| EmrAB-TolC | 7 | ||||
| ABC transport | 1 | ||||
| ppGpp synthesis (stringent response activation) | Stringent response | 4 | |||
| tRNA synthesis | 4 | ||||
| tRNA processing | 1 | ||||
| Cellular metabolism | 3 |
aAll mutants resistant to ciprofloxacin contained one mutation in the gyrA gene, except the K56-2 CIPR mutant that contained two mutations in gyrA and a mutation in parC